TRex Bio, Inc. Common stock (TRXB)

• Market cap: $385M
• 1 day: -1.06%
• 5 days: -1.27%
• 1 month: 0.07%
• 3 months: 0.07%
• 6 months: 0.07%
• Year to date: 0.07%
• 1 year: 0.07%
• 5 years: 0.07%
• 10 years: 0.07%
• Sector: Healthcare
• Industry: Biotechnology

About: Trex Bio Inc is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.